SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending after delivering an exceptionally strong earnings report and bullish future guidance, primarily driven by surging demand for its high-bandwidth memory essential for AI infrastructure. The community is buzzing with optimism, widely discussing whether this robust performance signals that the broader AI narrative is fully intact and poised to uplift the tech sector, challenging recent market skepticism around other semiconductor stocks.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending following significant announcements regarding its expansion into stock trading and prediction markets, sparking widespread community discussion. This move is being debated as either a strategic pivot to become a comprehensive financial operating system or a sign of bearish sentiment on the crypto market. Investors are actively assessing Coinbase's potential to compete with established platforms by diversifying its offerings and leveraging tokenization for future growth.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF (MSOS) is actively trending as the market anticipates an imminent executive order from President Trump to reclassify marijuana to Schedule III, potentially including vital banking reforms. This highly awaited move is driving significant community discussion and optimism, with investors foreseeing substantial benefits for US cannabis operators through reduced tax burdens and increased institutional investment. Many are holding strong, expecting a historic re-rating of the long-suppressed sector.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. (SOC) is trending as a federal designation confirmed its pipeline as an interstate facility, shifting regulatory authority and igniting debate on its path to renewed oil production. While many anticipate a significant operational restart and potential short squeeze, others remain cautious, highlighting continued state-level permit challenges and ongoing financial considerations. This development focuses community discussion on the interplay between offshore energy initiatives and regulatory frameworks.

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

Processa Pharmaceuticals (PCSA) is trending due to positive Phase 2 study data for its breast cancer treatment, NGC-Cap, which showed increased drug efficacy without heightened side effects. This news, following a recent reverse stock split, has fueled significant volatility and discussions around its potential impact on the company's valuation. The community is actively debating whether the sharp price movements reflect a genuine re-rating or a volatile "pump and dump" scenario, with many traders discussing short attacks and the risk of further dilution.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending as the community eagerly awaits NASA's multi-billion dollar Lunar Terrain Vehicle (LTV) Services contract award, which many believe the company is uniquely positioned to win. Investors highlight LUNR's proven flight heritage and independent lander development as key advantages, sparking discussions on its potential valuation against market fluctuations and the impending announcement.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is currently facing intense scrutiny and negative public sentiment in South Korea following a major data breach impacting millions of users and controversial responses from its leadership, including accusations of inadequate handling of worker safety incidents. This has led to heightened regulatory pressure, calls for boycotts, and widespread community discussion around CEO accountability, with some investors viewing the stock as oversold amid concerns of significant financial penalties and customer churn, while others anticipate a rebound due to the company's market dominance.

TOSHI

TOSHI is seeing a surge in conversation as the "Face of Base" meme coin, recently boosted by a Coinone KRW listing and ongoing speculation regarding future utility and major exchange listings. The community remains divided, with many actively "buying the dip" and expressing long-term conviction, while others voice frustration over market conditions and short-term price action.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is seeing intense trading volatility as natural gas futures prices whipsaw in response to constantly shifting cold and warm weather forecasts. The community is sharply divided between bulls anticipating a strong rebound from recent lows and bears capitalizing on further drops, frequently discussing the ETF's inherent decay and 'widowmaker' reputation.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is actively discussed as the U.S. cannabis sector anticipates a pivotal executive order to reschedule cannabis to Schedule III, a move expected to dramatically enhance profitability for multi-state operators by eliminating the restrictive 280E tax. The community views this as a potential "game changer" leading to a significant re-rating for undervalued American MSOs, with discussions also highlighting the company's recent market expansion and the long-term tailwind of state-level legalization efforts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 Biotech Stocks to Watch for Potential Upside

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position ARQT, FOLD, ANIP, TNGX and PCRX in this volatile sector. 

GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment

GSK secures FDA approval for Exdensur, the first twice-yearly biologic for treating severe asthma with an eosinophilic phenotype.

RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know

Rezolute shares collapse 79% so far in December after a phase III hyperinsulinism study of its only pipeline candidate miss primary and key secondary endpoints.

FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug

Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.

AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer

AstraZeneca's Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.

SNY Stock Down on Double Trouble With Multiple Sclerosis Drug

Sanofi shares slide after the FDA again delays its review of its MS drug tolebrutinib, and a phase III study fails to hit its primary endpoint.

KYTX Stock Rallies 23% on Upbeat Stiff Person Syndrome Study Data

Kyverna Therapeutics shares jump 23% after a registrational phase II study of miv-cel meets primary and all secondary efficacy goals for treating stiff person syndrome.

CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike

CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer

JNJ secures FDA approval to expand Akeega into earlier-stage prostate cancer, backed by strong phase III data and a first-of-its-kind precision combo.

GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU

GSK gets CHMP backing for Nucala in COPD and depemokimab in asthma, setting up possible Europe approvals in 2026 for IL-5 therapies.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Current Price	$82.35
Prev Close	$81.10
Open	$81.39
Dividend Yield	0.00%
50-Day Moving Average	$87.14
Beta	0.72
Avg. Volume	451,672.37
PE Ratio	50.50

52-Week High	$99.50
52-Week Low	$52.50
Market Capitalization	$1.83B
EPS (Annual)	-$1.04
Price to Book	3.66
Revenue Per Employee	$684,923.08
Enterprise Value/EBITDA	N/A

ANIP
ANI Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIP News

ANIPANI Pharmaceuticals Inc